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Gutierrez. A comparison of in vitro methods for assessing the potency of 
therapeutic antisera against the venom of the coral snake Micrurus nigrocinctus. 
To.uicon 35, 573-58 1, 1997.-Therapeutic antisera against Micrurus nigrocinc- 
tus venom were tested for protection against lethality, as well as for inhibition 
of the nicotinic acetylcholine receptor (AchR)-binding and neutralization of 
phospholipase A, (PLA?) activities of the homologous venom. Protection 
against venom lethality did not correlate with inhibition of AchR-binding 
activity, whereas there was a significant correlation between antisera potency 
and inhibition of PLA2 activity (r = 0.82, n = 10, P < 0.02). Inhibition of PLA, 
activity could be useful in assessing the protective efficacy of M. nigrocinctus 
antisera during antivenom production. Micrurus nigrocinctus nigrocinctus 
venom proteins were fractionated by cation-exchange chromatography on 
Mono S FPLC and fractions assayed for lethality, AchR-binding and PLA, 
activities. Antisera were titrated by enzyme-linked immunoassay (ELISA) 
against a crude M. n. nigrocinctus venom, two FPLC lethal fractions containing 
AchR-binding activity, and two toxins purified from M. n. nigrocinctus venom. 
No correlation was found between protective efficacy and the ELISA titer 
against any of these antigens. Compared to other elapid venoms that contain 
few toxins as major components, M. n. nigrocinctus venom appears to be more 
complex and its lethal effect is likely to be due to the combined effect of several 
neurotoxins. 0 1997 Elsevier Science Ltd. All rights reserved 
*Author to whom correspondence should be addressed. at: Microbiology and Tumorbiology Center. 
Karolinska Institutet, S-17 177 Stockholm, Sweden. 
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INTRODUCTION 
Micrurus snakes (New World coral snakes) are widely distributed from the south-eastern 
United States to Argentina (Campbell and Lamar, 1989). Severe envenomations by 
Micrurus snakes result in neurotoxic symptoms and require serotherapy (Russell, 1983; 
Kitchens and Van Mierop, 1987). Several laboratories in different countries produce 
therapeutic antivenoms by hyperimmunizing animals with crude venom from one or 
several Micrurus species (Theakston and Warrell, 1991; Gutierrez et al., 1991; Rawat et al., 
1994). Although mouse lethality assays are needed in the final testing of a given antivenom 
batch (WHO, 1981), more simple in vitro techniques are desirable for assessment of 
antivenom potency at earlier stages of antivenom preparation. 
The use of large antivenom volumes during serotherapy of snakebite envenomations 
increases the risk of serious side-effects (Sullivan, 1987). If animals were immunized only 
with the toxic venom components, the resulting antivenoms would probably be more 
efficacious, enabling the use of smaller volumes for serotherapy (Menez, 1991). Thus it 
would be desirable to identify and purify the most important toxins from a venom in order 
to prepare novel antigenic mixtures for the production of more efficacious antivenoms. 
Micrurus nigrocinctus is the most abundant, medically important coral snake in Central 
America (Alape-Giron et al., 1994a). The mouse LD5a of Micrurus nigrocinctus nigrocinctus 
venom is 0.765 mg/kg i.p. and 2 mg/kg S.C. (Gutierrez et al., 1991). In the mouse phrenic 
nervediaphragm, this venom induces electrophysiological nd ultrastructural changes that 
suggest he presence of postsynaptically and presynaptically acting toxins (Goularte et al., 
1995, 1996). We previously found that some components of M. n. nigrocinctus venom 
bind to the nicotinic acetylcholine receptor (AchR), and that antivenom inhibits the 
binding of homologous and heterologous a-neurotoxins to AchR (Alape-Giron el al., 
1996a,b). 
The aims of this study were to: (1) determine whether the potency of M. nigrocinctus 
antisera correlates with inhibition of AchR-binding and PLAz activities found in the 
homologous venom; (2) identify the lethal fractions of M. n. nigrocinctus venom; and (3) 
determine whether the protective efficacy of antisera correlates with the enzyme-linked 
immunosorbent assay (ELISA) titer against crude M. n. nigrocinctus venom, lethal 
fractions, or purified toxins. 
MATERIALS AND METHODS 
Venoms and toxins 
A pool of M. n. nigrocincrus venom was obtained from more than 100 specimens collected in the Pacific region 
of Costa Rica. Maja naja oxiana neurotoxin II (NT II) and Bungarus multicinctus cc-bungarotoxin were from 
Sigma (St Louis, MO, U.S.A.). Notechis scutatus scutatus notexin was kindly provided by Dr Bertil Persson 
(Uppsala University, Sweden). Mnn-4 and nigroxin B were purified from M. n. nigrocincms venom as described 
elsewhere (Alape-Giron et al., 1996b). 
Antisera 
Micrurus nigrocinctus antivenoms (batches 207, 221 and 232) were from Instituto Clodomiro Picado 
(Gutiirrez et al., 1991). Horse antisera against M. nigrocinctus venom were produced as described by Bolaiios 
and Cerdas (1980). Antiserum to N. s. scutatus notexin was prepared in rabbits (Alape-Giron et al., 1996b). 
Antiserum to N. n. oxiana neurotoxin II (NT II) was prepared in rabbits (2 kg body weight) by S.C. injection 
of native toxin (12.5 L(g) emulsified in Freund’s complete adjuvant (Difco, Detroit, MI, U.S.A.). Boosters were 
given s.c., three in Freund’s complete adjuvant and eight in Freund’s incomplete adjuvant, according to this 
scheme: days 12 and 29: 12.5 pg; days 36, 43, 50 and 57: 25 pg; days 67, 74 and 81: 30 ng; with bleeding on 
day 85. 
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FPLC,fractionaiion qf M. n. nigrocinctus venom proieins 
Micrurus nigrocinctus nigrocinctus venom samples dissolved in 1.5 ml of 0.05 M HEPES buffer, pH 8, were 
separated on a Mono-S HR 16/10 column using a Pharmacia FPLC instrument, a linear gradient of NaCl and 
a flow rate of 3 ml/min. Sixty-four fractions, 3 ml each, were collected and protein concentrations measured by 
the Bradford assay (Spector, 1978) using bovine serum albumin as a standard. 
Lethality, AchR-binding, and PLAz actkities of‘ venom jractions 
Lethality of the material corresponding to the separated peaks was determined by i.p. injection [I pg protein 
in 0.5 ml of phosphate-buffered saline, pH 7.2 (PBS)] into groups of four to eight Swiss-Webster mice (16-1X g). 
Deaths were recorded up to 72 hr. 
AchR-binding activity and competitive assays were performed as described previously (Stiles, 1991; 
Alape-Giron et crl., 1996b). In brief, 100 pl of purified AchR (50 pg/ml) was incubated with varying amounts 
of N. n. osiana NT II for 20 min at 22°C and the mixture added to wells coated with venom fractions. After 
a I hr incubation at 22°C plates were washed three times with PBS containing 0.1% Tween 20 (PBST), and 
guinea-pig antiserum to AchR [diluted in PBS containing 0.1% Tween-20 and 1% (w/v) gelatin, PBSTG] was 
put into wells. Following a 1 hr incubation at 22°C and four washes with PBST, goat anti-guinea-pig IgG-alkaline 
phosphatase conjugated was added for 1 hr at 22’C. Plates were washed five times with PBST, para-nitrophenyl 
phosphate diluted in diethanolamine buffer, pH 9.8, was added, and absorbances were read at 405 nm after 
30 min. 
PLA? activity was measured using an indirect hemolytic assay (Gutierrez rt al., 1988). Fractions diluted 1: 150 
in PBS were put into 4 mm wells in agarose gels containing 4% sheep erythrocytes, 4% egg yolk as a source 
of lecithin, and 10 mM CaCI,. The diameters of hemolytic halos were measured after a 20 hr incubation in a 
humidified chamber at 37’C. None of the fractions produced direct hemolysis in gels without egg yolk. 
In vivo neutrali:ation assa)s 
A fixed amount of M. n. nigrocinctus venom was incubated with varying amounts of antivenoms for 30 min 
at 37 C. Each mixture (0.5 ml). containing four LD~,,S of venom (52 pg), was injected i.p. into groups of four 
Swiss-Webster mice (1618 g) and deaths were recorded up to 72 hr. Controls received four LD~~,S of venom in 
PBS. Results were analyzed using PROBIT and neutralization was expressed as effective dose 50% (ED~& defined 
as the volume of antivenom (pl)/mg venom needed to prevent death in 50% of the injected mice. 
Inhibition qf AchR binding 
Inhibition of M. n. nigrocinctus venom binding to AchR by antivenoms was measured essentially as described 
previously (Alape-Giron er al., 1996a). In brief, Immulon II microtiter plates (Dynatech, Chantilly, VA, U.S.A.) 
were coated overnight at 4°C with M. n. nigrocinctus venom (5 pg/well). The remaining binding sites were 
blocked for 30 min at 37-C with 300 ~1 of PBS containing 1% (w/v) gelatin (PBSG), and then dilutions of 
antisera were added and incubated 30 min at 37’C. The AchR, guinea-pig anti-AchR serum, anti-guinea-pig 
alkaline phosphatase conjugate and para-nitrophenyl phosphate were serially added and absorbances recorded 
at 405 nm after 30 min. Control wells were incubated with a non-immune horse serum or an antivenom of 
non-related specificity. Inhibition curves were obtained by plotting the absorbance readings against the logarithm 
of antivenom dilutions, Results are expressed as effective dilution 50% (EDJ, defined as the dilution at which 
AchR binding was inhibited by 50% compared to wells incubated in parallel with PBSG instead of antiserum. 
Itlhihition of PLAZ actkit? 
Inhibition of M. n. nigrocinctus PLA, activity by antivenoms was measured as described by Gutiirrez rr 01. 
(1988). In brief, a constant amount of venom was incubated with different dilutions of antivenom for 30 min 
at 37C. Then, IO 111 of each mixture (containing 1.2 pg of venom) was added to duplicate wells in 
agdroseerythrocyte-egg yolk gels. The diameter of the hemolytic halos was measured and inhibition of PLA, 
activity was calculated as a percentage of the hemolysis caused by venom alone. A non-immune horse serum 
or an antivenom of non-related specificity was used as control. Inhibition of PLA? activity was expressed as 
effective dose 50%. defined as the volume of antivenom (~1) required to reduce by 50% the PLA2 activity of 
I mg of venom. ED<,, values were obtained for each antivenom in three independent experiments. 
EL1SA.r 
Microtiter plates were coated overnight at 22C with 0.5 pg protein/well, dissolved in carbonate buffer, pH 
9.6. The remaining binding sites were blocked with 150 @I of 2% bovine serum albumin (blocking solution) for 
15 min at 37‘C. Various dilutions of antivenoms in blocking solution were then added (100 ~l/well). After a 1 hr 
incubation at 37 C and five washes with a Tris 50 mM, NaCl 150 mM, ZnCb 0.020 mM, MgCI, 1 mM buffer, 
pH 7.4, 100 ~1 of anti-horse IgG-alkaline phosphatase conjugate (Sigma) was added per well. After a I hr 
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incubation at 37°C plates were washed five times and 100 $/well of a para-nitrophenyl phosphate substrate 
solution (1 mg/ml) diluted in diethanolamine buffer, pH 9.8, was added. Absorbances were recorded at 405 nm 
after 60 min. Titration curves were obtained by plotting the absorbance readings against the logarithm of 
antivenom dilutions. The titer was defined as the inverse logarithm of the dilution giving 0.5 absorbance units. 
Negative controls on each plate were either non-immune horse serum or an antivenom of non-related specificity. 
Dilutions of a M. nigrocirzctus antivenom (batch 207) were included on every plate as a reference sample to control 
plate-to-plate variations. 
RESULTS 
Neutralization of M. n. nigrocinctus venom by antivenoms 
The potencies of ten M. nigvocinctus antivenom samples to protect against lethality in 
mice and their abilities to inhibit AchR-binding and PLA, activities of the homologous 
venom are shown in Table 1. Intraperitoneal injection of 4 LD,, of venom caused 
respiratory failure and death within 2 hr. Antivenoms protected against lethality of M. IZ. 
nigrocinctus venom with ED& ranging from 2732 to 7519 pl/mg. Antivenoms inhibited the 
binding of M. n. nigrocinctus a-neurotoxins to AchR with EDITS ranging from 217 to 
2250 pl/mg, but no correlation was found between the protective efficacy and inhibition 
of AchR-binding (Y = 0.34; P > 0.05). Antivenoms inhibited the PLA, activity with EDITS 
ranging from 108 to 515 pl/mg, which correlated significantly with protection against 
lethality (r = 0.82; P < 0.02). 
Lethality of M. n. nigrocinctus venom fractions 
Micrurus nigrocinctus nigrocinctus venom basic proteins were separated in 19 peaks on 
Mono S FPLC (Fig. 1). A mixture containing M. n. mgrocinctus venom proteins with 
isoelectric points lower than 8.0 (material not bound to the Mono S) was not lethal when 
injected i.p. into mice at a dose of 55-62 pg/kg. In contrast, material corresponding to ten 
of the 19 peaks separated by Mono S (peaks IV, IX, XI-XVII, and XIX, marked by 
asterisk in Fig. 1) was lethal at that dose. Material corresponding to peak IV caused flaccid 
Table 1. Potency of M. nigrocinctus antivenoms to protect against lethality 
of the homologous venom and inhibition of AChR-binding and PLA, 
activities 
Antivenom 
sample no. 
Lethality 
(E&u)* 
AChR binding 
(ED& 
PLA* activity 
(ED& 
1 7519 504 438 
2 7042 1435 372 
3 6135 475 515 
4 6135 217 279 
5 5000 689 183 
6 5000 n.t.5 280 
7 4386 712 214 
8 4184 984 108 
9 4098 2250 204 
10 2732 1004 141 
*Amount (~1) of antivenom/mg venom needed to protect half of the mice 
injected with 4 LD5” of venom. 
l-Dilution at which the AChR-binding activity was inhibited by 50% 
compared with control wells incubated without antiserum. 
JAmount (~1) of antivenom required to reduce by 50% the PLA, activity 
of 1 mg of venom. 
gjNot tested. 
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Fig. I. Elution profile of M. n. nigrocinctus venom (120 mg) on Mono S FPLC with a linear 
gradient of NaCI. 
Solvent A: 0.05 M HEPES, pH 8.0; solvent B: solvent A + 1 M NaCI. Gradient: O-48’% B in 
60 min. Lethal peaks are noted by asterisks and peaks with PLA, activity are indicated by dashed 
lines at the bottom. 
paralyis, breathing difficulties, and death in less than 30 min after injection, whereas time 
to death caused by the other fractions was longer than 2 hr. 
Material corresponding to peaks IV and XVI (fractions 17-19 and 46649, respectively) 
was lethal and contained AchR-binding activity that was dose-dependently inhibited by 
N. 12. oxiana NT II (Table 2) suggesting that M. n. nigrocinctus venom contains several 
a-neurotoxins with different charges. Moroever, material corresponding to peak IV was 
recognized in an ELISA by antibodies to N. n. osiuna NT II, which also inhibited its 
binding to AchR (data not shown). These results strongly suggest that peak IV contains 
short-chain x-neurotoxin(s), which share neutralizing epitope(s) with N. n. olvianu NT II. 
PLA, activity was detected in material corresponding to peaks VIII-IX, XII-XIII and 
XVI-XIX (Fig. 1) and, furthermore, this material was recognized in an ELISA by 
antibodies to N. s. scututus notexin (data not shown). 
Titrution qf’ antivenoms 
Micrurus nigrocinctus antivenoms were titrated against one presynaptic toxin, N. s. 
scututus notexin, and two postsynaptic toxins: a long-chain a-neurotoxin, B. multicinctus 
a-bungarotoxin, and a short-chain a-neurotoxin, N. n. oxiuna neurotoxin II (data not 
shown). No correlation was found between the potency of antivenoms to protect against 
lethality and the ELISA titers against any of those heterologous toxins. 
Antivenoms were titrated by ELISA against crude M. n. nigrocinctus venom and lethal 
fractions with AchR-binding activity, corresponding to peaks IV and XVI (Table 3). No 
significant correlation was found between antivenom potency and ELISA titer against 
crude venom or any of the AchR-binding fractions. Antivenoms were also titrated against 
two toxins purified from M. n. nigrocinctus venom: Mnn-4, an AchR-binding protein, and 
nigroxin B, a basic PLA, (Table 3). No correlation was found between antivenom potency 
and the ELISA titer against any of these homologous toxins. 
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Table 3. ELISA titer of M. nigrocinctus antivenoms against the homologous venom, lethal 
fractions with AChR-binding activity, and two purified toxins 
Antivenom 
samnle no. Crude venom 
Titers* to 
Peak IV Peak XVI Mnn-4 Nigroxin B 
3.2 2.5 2.5 3.4 4.0 
4.3 3.3 3.6 3.4 4.3 
4.0 3.6 3.1 3.4 4.9 
3.1 2.5 2.4 3.0 3.5 
4.1 3.3 3.4 3.3 4.4 
n.t.1 nt. n.t. 3.5 4.2 
3.9 3.2 3.4 3.3 4.3 
3.7 2.9 2.9 3.4 4.0 
4.1 3.6 3.9 3.2 4.0 
3.6 2.1 2.6 3.4 3.5 
*Negative log of the dilution giving 0.5 absorbance units 
PNot tested. 
DISCUSSION 
Micrurus nigrocinctus antivenoms contain antibodies which neutralize the lethal effect 
of the neurotoxins present in the homologous venom, as determined by mouse lethality 
assays. We previously reported the use of an AchR-binding assay to evaluate the ability 
of M. nigrocinctus antivenoms to inhibit binding of M. n. nigrocinctus a-neurotoxins to 
AchR (Alape-Giron et al., 1996a). In the present work, we found no correlation between 
antivenom potency and inhibition of M. N. nigrocinctus a-neurotoxins binding to AchR. 
In contrast, antivenom potency correlated significantly with inhibition of PLAz activity 
found in M. n. nigrocinctus venom. This finding suggests a role for toxic PLAzs in M. n. 
nigrocinctus venom lethality. Alternatively, antibodies that inhibit PLA,s may parallel the 
presence of antibodies against another lethal toxin(s). Anyhow, inhibition of PLAz activity 
is a simple and inexpensive assay, which could be useful in initial potency assessments of 
M. nigrocinctus antisera, minimizing the need for mouse lethality assays during antivenom 
production. For antisera to Crotalus durissus terrifi’cus venom, there is a good correlation 
between neutralization of PLAz and lethal activities of homologous venom (Da Silva and 
Bier, 1982). The component responsible for the lethal effect of C. d. terr!$cus venom is 
crotoxin, a neurotoxic PLA, that constitutes 68% of the total venom protein (Hanashiro 
L’I al., 1978). This work shows that M. n. nigrocinctus venom contains multiple PLAzs with 
different charges, that are antigenically related to N. S. scutatus notexin, the most toxic 
monomeric venom PLA, (Mollier et al.. 1989). Interestingly, N. s. scutatus antivenom was 
reported to protect against the lethal effect of Micrurus ,fulvius venom (Minton, 1967) 
which is antigenically very similar to that of M. n. nigrocinctus (Bolaiios et al., 1978; 
Alape-Giron et al., 1994b). Micrurus corallinus and M. n. nigrocinctus venoms exert both 
postsynaptic and presynaptic effects on neuromuscular transmission (Vital-Brazil and 
Fontana, 1983/84; Goularte et al., 1995). Furthermore, these two venoms induce an 
increase in the number of omega-shaped axolemmal indentations and a decrease in the 
number of synaptic vesicles at the motor nerve terminal in mouse phrenic nerve-diaphragm 
preparations, suggesting that M. corallinus and M. n. nigrocinctus venoms contain 
neurotoxic PLA,s (Cruz-Hofling et al., 1983/84; Goularte et al., 1996). Lethal FPLC 
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fractions from M. n. nigrocinctus venom with PLAz activity might contain some of these 
neurotoxic PLA,s. 
It has been recently suggested that the chick biventer cervicis preparation could be used 
to assess the protective activity of antivenoms to neutralize the neuromuscular effects of 
neurotoxic snake venoms (Barfaraz and Harvey, 1994). Since there are both 
presynaptically and postsynaptically acting toxins in M. n. nigrocinctus venom, it would 
be interesting to test whether there is a correlation between this technique and mouse 
lethality assays for M. nigrocinctus antivenoms. 
Theakston and Reid (1979) reported the use of ELISAs with crude venoms as antigens 
to assess the potency of viperid and elapid antivenoms. More recently, Rungsiwongse and 
Ratanabanangkoon (1991) suggested that ELISAs using lethal toxin-containing fractions 
as antigens would provide better estimates of the potency of elapid antivenoms. These 
authors found a good correlation between the potency of Naja naja siamensis antivenoms 
and the ELISA titer against a fraction containing a-cobratoxin, the major a-neurotoxin 
of N. n. siamensis venom that constitutes 35% of the total venom protein (Karlson et al., 
1971). However, in the case of M. nigrocinctus antivenoms, we observed no correlation 
between potency and the ELISA titers against either crude venom, AchR-binding 
fractions, or purified toxins. 
The findings suggest that M. n. nigrocinctus venom contains multiple a-neurotoxins and 
toxic PLA, isoforms, but not a single predominant lethal toxin. It is very likely that the 
lethality of M. n. nigrocinctus venom results from the combined action of several 
neurotoxins. Although M. nigrocinctus antivenom potency correlates with the ability to 
inhibit PLA, activity of the homologous venom, further studies will be needed to clarify 
the role of toxic PLA,s and a-neurotoxins in the lethal effect of M. n. nigrocinctus venom. 
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